UBS Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $77.4M | Sell |
|
|||||
|
2025
Q2 | $65.4M | Buy |
|
|||||
|
2025
Q1 | $40.8M | Buy |
|
|||||
|
2024
Q4 | $49.6M | Buy |
|
|||||
|
2024
Q3 | $35.7M | Buy |
|
|||||
|
2024
Q2 | $32.8M | Buy |
|
|||||
|
2024
Q1 | $35.3M | Buy |
|
|||||
|
2023
Q4 | $29M | Buy |
|
|||||
|
2023
Q3 | $26.7M | Sell |
|
|||||
|
2023
Q2 | $32.3M | Buy |
|
|||||
|
2023
Q1 | $28.7M | Buy |
|
|||||
|
2022
Q4 | $4M | Buy |
|
|||||
|
2022
Q3 | $3.41M | Sell |
|
|||||
|
2022
Q2 | $9.35M | Sell |
|
|||||
|
2022
Q1 | $14.1M | Sell |
|
|||||
|
2021
Q4 | $41.4M | Sell |
|
|||||
|
2021
Q3 | $46.7M | Buy |
|
|||||
|
2021
Q2 | $36.1M | Buy |
|
|||||
|
2021
Q1 | $25.9M | Buy |
|
|||||
|
2020
Q4 | $26M | Buy |
|
|||||
|
2020
Q3 | $12.1M | Sell |
|
|||||
|
2020
Q2 | $14.4M | Buy |
|
|||||
|
2020
Q1 | $8.6M | Sell |
|
|||||
|
2019
Q4 | $17.7M | Buy |
|
|||||
|
2019
Q3 | $5.24M | Buy |
|
|||||
|
2019
Q2 | $4.05M | Sell |
|
|||||
|
2019
Q1 | $4.41M | Buy |
|
|||||
|
2018
Q4 | $2.9M | Sell |
|
|||||
|
2018
Q3 | $4.53M | Sell |
|
|||||
|
2018
Q2 | $3.68M | Sell |
|
|||||
|
2018
Q1 | $4.1M | Buy |
|
|||||
|
2017
Q4 | $4.32M | Buy |
|
|||||
|
2017
Q3 | $3.94M | Sell |
|
|||||
|
2017
Q2 | $5.3M | Buy |
|
|||||
|
2017
Q1 | $2.91M | Buy |
|
|||||
|
2016
Q4 | $2.99M | Buy |
|
|||||
|
2016
Q3 | $2.42M | Sell |
|
|||||
|
2016
Q2 | $5.29M | Buy |
|
|||||
|
2016
Q1 | $1.71M | Sell |
|
|||||
|
2015
Q4 | $1.57M | Sell |
|
|||||
|
2015
Q3 | $1.47M | Buy |
|
|||||
|
2015
Q2 | $1.57M | Sell |
|
|||||
|
2015
Q1 | $1.63M | Buy |
|
|||||
|
2014
Q4 | $1.41M | Buy |
|